Log In
BCIQ
Print this Print this
 

ALX-101

  Manage Alerts
Collapse Summary General Information
Company Alexar Therapeutics Inc.
DescriptionLiver X Receptor (LXR) agonist
Molecular Target Liver X receptor (LXR)
Mechanism of ActionLiver X receptor (LXR) agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDermatitis
Indication DetailsTreat mild to moderate atopic dermatitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today